Online citations, reference lists, and bibliographies.
← Back to Search

Sedative Effects Of Levocetirizine: A Systematic Review And Meta-Analysis Of Randomized Controlled Studies

K. Snidvongs, K. Seresirikachorn, L. Khattiyawittayakun, W. Chitsuthipakorn
Published 2016 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
IntroductionAs a substrate of P-glycoprotein, levocetirizine should not cause sedative effects. However, while cetirizine, a mixture of levocetirizine and dextrocetirizine, can slightly penetrate the blood brain barrier, the sedative effects of levocetirizine are still under study.ObjectivesThe aim of this study was to investigate the sedative effects of levocetirizine.MethodsAn electronic literature search was performed using Medline and EMBASE from January 01, 2001 through August 6, 2015. Randomized controlled trials (RCTs) comparing levocetirizine with other antihistamines or placebo for patients with allergy and healthy subjects were selected. Primary outcome was risk ratio between levocetirizine and comparators. Secondary outcome was change in psychomotor speed. Data were pooled for meta-analysis using a fixed-effect model.ResultsForty-eight studies of 18,014 patients met the inclusion criteria. When compared to placebo, levocetirizine produced modest sedative effects (RR: 1.67; 95% CI 1.17, 2.38). However, when compared to other second-generation antihistamines, sedative effects of levocetirizine did not differ (RR: 1.23; 95% CI 0.96, 1.58). In subgroup analysis, there was no difference between the sedative effects of levocetirizine and fexofenadine (RR: 1.7; 95% CI 0.59, 4.88), desloratadine (RR: 1.58; 95% CI 0.9, 2.77), loratadine (RR: 1.56; 95% CI 0.28, 8.56), bilastine (RR: 1.17; 95% CI 0.48, 2.84), olopatadine (RR: 1.09; 95% CI 0.81, 1.47), azelastine (RR: 0.19; 95% CI 0.01, 3.68) and rupatadine (RR: 1.47; 95% CI 0.14, 15.72). When compared to first-generation antihistamines, levocetirizine had less sedative effects and less change of reaction time (mean difference: −250.76 s; 95% CI −338.53, −162.98).ConclusionLevocetirizine has modest sedative effects with a risk ratio of 1.67 when compared with placebo. The sedative effects observed for levocetirizine are not different from other second-generation antihistamines.
This paper references
10.1159/000331329
The Loss of Smell in Persistent Allergic Rhinitis Is Improved by Levocetirizine due to Reduction of Nasal Inflammation but Not Nasal Congestion (the CIRANO Study)
J. Guilemany (2012)
10.1111/j.1365-4632.2005.02609.x
Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double‐blind, placebo‐controlled, parallel, multicenter study
A. Kapp (2006)
10.1002/14651858.cd001267
Antihistamines for the common cold.
A. I. Sutter (2003)
10.1034/j.1398-9995.2001.00726.x
A randomized, double‐blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine‐induced cutaneous responses in healthy adult volunteers
J. Devalia (2001)
10.1185/03007995.2012.672405
Safety considerations in the management of allergic diseases: focus on antihistamines
K. Yanai (2012)
10.1517/14740338.2015.989831
Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine
K. Hiraoka (2015)
10.1097/WOX.0b013e3181f8dabb
Challenges in the Management of Chronic Urticaria
T. Popov (2011)
10.1111/j.1365-2222.2006.02478.x
Effects of levocetirizine as add‐on therapy to fluticasone in seasonal allergic rhinitis
M. Barnes (2006)
10.4103/0253-7613.62399
Loratadine versus levocetirizine in chronic idiopathic urticaria: A comparative study of efficacy and safety
P. Anuradha (2010)
10.1185/030079904125003700
A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit – the Vienna Challenge Chamber (VCC)
P. Stübner (2004)
10.1016/j.anai.2009.12.003
Efficacy and safety of levocetirizine in improving symptoms and health-related quality of life in US adults with seasonal allergic rhinitis: a randomized, placebo-controlled study.
N. Segall (2010)
10.2174/187152811794352033
Anti-inflammatory activity and clinical efficacy of a 3-month levocetirizine therapy in mite-allergic children.
F. Marcucci (2011)
10.1001/archoto.2010.128
Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety.
R. Maiti (2010)
10.1034/J.1398-9995.2003.00171.X
Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites.
Potter Pc (2003)
10.1111/j.1399-3038.2005.00216.x
Levocetirizine in children: evidenced efficacy and safety in a 6‐week randomized seasonal allergic rhinitis trial
J. de Blic (2005)
10.1016/J.JACI.2004.05.070
Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis.
C. Bachert (2004)
10.1111/ijd.12733
Levocetirizine and rupatadine in chronic idiopathic urticaria
Madhulika Johnson (2015)
10.1111/j.1398-9995.2008.01893.x
Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients
P. Potter (2009)
10.1046/J.1365-2125.2003.01897.X
Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin.
A. Purohit (2003)
10.1016/j.anai.2011.08.012
Comparison of the sedating effects of levocetirizine and cetirizine: a randomized, double-blind, placebo-controlled trial.
D. B. Tzanetos (2011)
A randomized, double-blind, cross-over comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers
JL Devalia (2001)
Efficacy and Safety of Azelastine and Levocetirizine in Allergic Rhinitis
S. Mahajan (2013)
10.1016/S1081-1206(10)61208-2
Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial.
P. Potter (2005)
10.1111/j.1399-3038.2007.00558.x
Safety of levocetirizine treatment in young atopic children: An 18‐month study
F. Simons (2007)
10.1016/j.clinthera.2009.05.017
A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
C. Bachert (2009)
10.2340/00015555-1490
The inhibition by levocetirizine and fexofenadine of the histamine-induced wheal and flare response in healthy Caucasian and Japanese volunteers.
N. Schoepke (2013)
10.1111/j.1368-5031.2004.0117.x
Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU)
J. Day (2004)
10.3109/09546634.2012.750414
Olopatadine versus levocetirizine in chronic urticaria: an observer-blind, randomized, controlled trial of effectiveness and safety
A. Sil (2013)
10.1111/J.1365-2125.2005.02377.X
Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration.
F. Horak (2005)
Levocetirizine improves nasal symptoms and airflow in patients with persistent allergic rhinitis: a pilot study.
G. Ciprandi (2005)
10.1111/j.1398-9995.2009.02217.x
Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi‐centre, double‐blind, randomized, placebo‐controlled study
T. Zuberbier (2010)
10.1007/s00213-003-1462-6
Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial
J. Verster (2003)
Pharmacokinetic overview of oral second-generation H1 antihistamines.
G. Ma (1998)
Pharmacokinetic and bioequivalence evaluation of two formulations of levocetirizine 5 mg in healthy Thai volunteers
C. Jantarat (2013)
10.5372/1905-7415.0903.408
Fexofenadine and levocetirizine have equivalent effectiveness for persistent allergic rhinitis
K. Snidvongs (2015)
10.1111/j.1365-2222.2006.02548.x
Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters
M. Pasquali (2006)
10.1016/S1081-1206(10)61995-3
A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
J. Grant (2002)
10.1111/j.1365-2133.2005.07049.x
Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double‐blind, placebo‐controlled study
E. Nettis (2006)
10.1034/j.1398-9995.2001.00775.x
Effect of cetirizine, levocetirizine, and dextrocetirizine on histamine‐induced nasal response in healthy adult volunteers
D. Wang (2001)
10.1111/j.1399-3038.2008.00816.x
The comparison of cetirizine, levocetirizine and placebo for the treatment of childhood perennial allergic rhinitis
Chih-Fang Lee (2009)
10.1186/1710-1492-9-43
Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design
R. Muñoz-Cano (2013)
10.1111/1346-8138.12326
Evaluation of the antihistamine effects of olopatadine and levocetirizine during a 24‐h period: A double‐blind, randomized, cross‐over, placebo‐controlled comparison in skin responses induced by histamine iontophoresis
T. Takeo (2013)
10.2500/aap.2010.31.3349
Safety and tolerability of levocetirizine dihydrochloride in infants and children with allergic rhinitis or chronic urticaria.
F. Hampel (2010)
10.1016/S1081-1206(10)60494-2
Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients.
P. Patel (2008)
Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration
Jp Higgins (2011)
10.1159/000080657
Comparison of the Effects in the Nose and Skin of a Single Dose of Desloratadine and Levocetirizine over 24 Hours
G. Passalacqua (2004)
10.1159/000350926
Randomized Double-Blind Study of Prophylactic Treatment with an Antihistamine for Seasonal Allergic Rhinitis
S. Yonekura (2013)
10.1185/0300799019117011
The Acute and Sub-chronic Effects of Levocetirizine, Cetirizine, Loratadine, Promethazine and Placebo on Cognitive Function, Psychomotor Performance, and Weal and Flare
I. Hindmarch (2001)
10.3357/ASEM.2212.2008
Fexofenadine effects on cognitive performance in aviators at ground level and simulated altitude.
Charles Vacchiano (2008)
10.1111/j.1365-2222.2004.01960.x
Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study
G. Ciprandi (2004)
10.2500/ajra.2011.25.3668
Nasal Nitric Oxide and Nasal Eosinophils Decrease with Levocetirizine in Subjects with Perennial Allergic Rhinitis
A. Bautista (2011)
Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration
J. Higgins (2013)
10.1046/J.1365-2125.2002.01611.X
Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers.
J. Gandon (2002)
10.3109/13651501.2014.907919
Assessment of the effects of antihistamine drugs on mood, sleep quality, sleepiness, and dream anxiety
P. Ozdemir (2014)
10.1185/03007991003745233
Study of levocetirizine in seasonal allergic rhinitis
L. Mansfield (2010)
10.1016/j.jaad.2010.03.007
A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria.
Jin-Bon Hong (2010)



This paper is referenced by
10.2147/DDDT.S215316
The Effect Of Food On The Pharmacokinetic Properties And Bioequivalence Of Two Formulations Of Levocetirizine Dihydrochloride In Healthy Chinese Volunteers
Y. Cheng (2019)
10.1007/s12070-020-02249-2
Efficacy and Safety of Diethylcarbamazine in Treatment of Allergic Rhinitis: A Double Blind Randomised Controlled Trial
S. Mohana Karthikeyan (2020)
10.1016/j.bjorl.2017.10.006
IV Brazilian Consensus on Rhinitis - an update on allergic rhinitis.
E. Sakano (2017)
10.1186/s40360-019-0363-1
Antihistamine effects and safety of fexofenadine: a systematic review and Meta-analysis of randomized controlled trials
Chengzhi Huang (2019)
10.1038/s41397-019-0094-0
Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria
J. Li (2019)
IN PRESS + Model IV Brazilian Consensus on Rhinitis : 2017 update 3 Importance of guidelines for allergic rhinitis management
E. Sakano (2017)
10.1016/BS.SEDA.2017.06.003
Antihistamines (H1 Receptor Antagonists)
Tyler S. Dougherty (2017)
10.1016/j.jpba.2017.07.059
Development and validation of a GC–MS method for the determination of hydroxyzine and its active metabolite, cetirizine, in whole blood
M. Katselou (2017)
10.1007/s12247-020-09465-x
A Comparative Study of Levocetirizine Loaded Vesicular and Matrix Type System for Topical Application: Appraisal of Therapeutic Potential against Atopic Dermatitis
Ravi Raj Pal (2020)
10.1007/s11882-020-00922-8
Utility of Environmental Exposure Unit Challenge Protocols for the Study of Allergic Rhinitis Therapies
Lubnaa Hossenbaccus (2020)
Semantic Scholar Logo Some data provided by SemanticScholar